 An Introduction to Medical Device Regulations
This course has been designed for professionals in regulatory affairs, clinical affairs and quality assurance, who are either newcomers to medical device regulation or are merely looking for a refresher.
This comprehensive 2-day course encompasses all the latest regulatory developments with a particular emphasis on European Community legislative developments, particularly the Revisions to the Medical Device Directive which were published in September.
Our leading panel of experts offers the latest regulatory update and practical advice through short talks, practical examples and interactive breakout sessions.
This is an idea opportunity to increase understanding, bring questions to the forefront and ultimately ensure that regulatory compliance.
|
|
|
|
|
 Utilisation of amorphous materials in drug development
Informa Lifesciences amorphous materials conference is the only event to specifically address the issues faced in industry by the use of amorphous materials in pharmaceuticals. This 2 day conference presents many case studies, illustrating the challenges faced and how they were overcome. The programme covers many topics including stability of amorphous materials from characterisation through manufacture, pre-formulation and formulation through to shelf life. Also covered are production techniques, bioavailability, functionality, registration of an amorphous drug and intellectual property. This conference will allow delegates to explore the influences of these amorphous forms and discuss experiences with others to help find solutions.
It is to be held at the Hotel Silken Berlaymont, Brussels, Belgium.
|
|
|
|
|
 Cell-Based Assays
Cell-Based Assays 2008 will provide first-hand insight into the current and arising cell-based technologies being employed to enhance drug discovery screening processes. Attendees will meet primary researchers, technology developers and industry end-users and leaders to discuss which technologies are proving viable, how to overcome problems of specificity and reliability and allow you to gain practical feedback of their own experiences, successes and failures.
|
|
|
|
|
 Project Management in Clinical Trials
Informa Life Sciences’ 1st Project Management in Clinical Trials conference is the only event in Europe focusing solely on the current issues facing project managers within the pharmaceutical industry. This conference will look into the issues of project manager recruitment improving supplier-client relationships, project manager recruitment and utilising key tools and methods to improve overall project management practices.
Featuring presentations and case studies from professionals within and outside the industry, this conference promises to be a key event in the industry. Topics including Contractual management of projects, Trust and Transparency: necessities for successful financial management, Assessing required skill sets to optimise project manager efficiency and Project Manager Office: Supporting the project manager role presented by highly regarded individuals are all part of a well researched agenda to help you and your company find the solutions to the issues in project management you currently face.
|
|
|
|
|
 Medical Device Regulations in Asia-Pacific
Japan is currently the second largest market for medical devices in the world, with China tipped to overtake it in the next two years. India is hot on their heels showing signs of being a crucially profitable market of the future.
Entering these markets can be difficult due to complicated ever changing regulatory frameworks, a lack of harmony in regulations and cultural differences.
Informa Life Sciences' 2nd Annual 'Market Access for Medical Devices into Asia-Pacific' will equip you with the know-how to access these markets, and 4 other crucial markets in the region, quickly and effectively. Through regulatory updates and case study presentations from industry thought leaders, you will gain insight and knowledge to put into practice when you get back to the office.
|
|
|
|
|
 Comparability for Biologics
Two-day conference with three workshops presenting case studies and in-depth reports on stratgy, analytical technologies, functional assays, and EU and US regulatory issues.
|
|
|
|
|
 Data Management for the Pharmaceutical Industry
Informa Life Sciences are delighted to announce the 2008 ‘Data Management for the Pharmaceutical Industry’ conference. Aimed at those working within the clinical data management role and taking place in London on the 9 – 10th July 2008, this conference will provide a one stop shop for data management professionals.
|
|
|
|
|
 Clinical Trials Summer School
This three day course is an introduction for people entering into Clinical Trials. Senior representatives of the pharmaceutical industry and associated bodies will provide discussion and clarification of the key areas of importance to someone entering the industry.
|
|
|
|
|
 Particle Design for APIs and Drug Products
This 2nd time event is designed to bring together industry professionals together from formulation, preformulation and chemistry to share experiences and learn about the latest techniques and ideas used in design particles. Particle design is becoming more widely used by industry to maximise the functionality and properties of the particle, ensure it has the desired effect. This conference covers characterisation, production and formulation of designed particles, as well as a 1 day symposium on nanoparticles, looking into the various challenges faced by industry in this area.
|
|
|
|
|
 Pharmaceutical Summer School
This 3-day residential course will take you step by step through the entire drug development pipeline, giving you the knowledge and understanding essential to create a wider perspective of your role within the industry. Taught by experts from across the pharmaceutical industry, this is your opportunity to understand how each department works together throughout the product development process.
|
|
|
|
|
 5th Annual Congress: Partnering with Central Labs, Cardiology and Imaging Labs Europe
Studies have shown that conducting clinical trials represents an average of 37% of the total cost to bring a new medicinal product to market, and central laboratory testing represents a critical step in supporting the evaluation of a new product. Central lab services have become a crucial component in more than 70% of all clinical trials worldwide, by helping reduce drug development costs and speed up drug development cycle times, it has become more important than ever.
The 5th Annual Congress: Partnering with Central Labs, Caridiology and Imaging Labs Europe has become the most comprehensive event in Europe to focus only on aligning sponsors, central labs, ECG and Imaging labs in collaborative partnerships that aim to improve process efficiencies to advance drug development. This annual congress will address the timely and challenging issues of building strong long-term relationships, data integration and management problems, new and future trends in the central lab industry and outsourcing strategies.
|
|
|
|
|
|
|
 Medical Device Law and Compliance
Informa Life Sciences have designed a detailed, in-depth and practical forum to enable you to conduct business without being confronted with potential infringement to legislation. This comprehensive programme enables you to develop your knowledge and competency in medical device regulatory and compliance challenges.
|
|
|
|
|
 6th Annual: Clinical Trial Supplies and Packaging Summit
The clinical supply chain is a complex mechanism, consisting of medical products, patient-related goods and supplies used by service facilities. Timing and accuracy are two of the most important criteria to be considered when managing the supply chain. Indeed, clinical trial supplies must be delivered at the right quantity, right place and right time. Therefore, pharmaceutical companies must concentrate on streamlining the clinical supply chain to maximise efficiencies and protect their own financial well being.
The IIR 6th Annual Clinical Trial Supplies and Packaging Summit has become an established event in the industry, providing each year new solutions to emerging challenges affecting the management of clinical supplies.
|
|
|
|
|
|
|
 BioProduction 2008
BioProduction 2008 Conference and Exhibition is the premier event to attend this autumn for a comprehensive update on operational strategies, technologies, regulatory changes, manufacturing production and process development. Develop key relationships and obtain fresh ideas on how to benchmark your best practices. Network with your peers and evaluate new technologies and processes on how to get to market quicker.
|
|
|
|
|
 Drug Delivery Partnerships
DDP is Europe's premier drug delivery conference – a MUST for those working in this industry. As an industry that is extremely partnership-intensive, commercial success requires strategic collaboration, this ideal and dynamic event provides an ideal opportunity to connect with potential partners. Delivering the latest strategies, business models, industry updates and networking functions to help position your company for a successful partnership/collaboration, this event is not to be missed.
|
|
|
|
|
 Preclinical and clinical safety testing for new drugs
On the 2nd and 3rd of December 2008, Informa will hold the 2nd Annual Preclinical and clinical safety testing for new drugs conference in Basel, Switzerland.
This year attendees willl gain a balanced look at safety testing in target organs, from the liver to the CNS, including topics such as ‘reactive metabolites as a preclinical warning for idiosyncratic liver toxicities’ and ‘whats missing from your pre-clinical toolkit to more accurately predict QT risk’.
With new regulations and guidelines from the FDA, EMEA and ICH defining the way the industry will have to perform your safety tests, we will ensure delegates will have the chance to hear from the regulators, including the MHRA, about what they expect from their safety reports and what plans they’ll need to put in place to be compliant.
Finally, improve the predictability of your safety tests by attending sessions on improving study designs for your first in man trials, and how to select the right animal model for your preclinical study.
This year be sure to attend 'Preclinical and clinical safety tests for new drugs' to improve the predictability of your pre-clinical safety tests and ensure efficient translation from the pre-clinical to clinical stage.
|
|
|
|
|